Genetic sequencing company will take full ownership of group developing liquid biopsy
Home/FT/Illumina agrees $8bn deal for cancer screening start-up Grail FT Illumina agrees $8bn deal for cancer screening start-up Grail Financial Times0 Less than a minute Facebook X LinkedIn Genetic sequencing company will take full ownership of group developing liquid biopsy Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)Click to share on WhatsApp (Opens in new window)Click to email a link to a friend (Opens in new window) Related Financial Times0 Less than a minute Facebook X LinkedIn Facebook X LinkedIn Tumblr Pinterest Reddit VKontakte Share via Email Print